Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Minority Interest (2016 - 2018)

Traws Pharma (TRAW) has disclosed Minority Interest for 6 consecutive years, with $830000.0 as the latest value for Q1 2018.

  • For Q1 2018, Minority Interest changed 0.0% year-over-year to $830000.0; the TTM value through Mar 2018 reached $830000.0, changed 0.0%, while the annual FY2017 figure was $830000.0, 0.0% changed from the prior year.
  • Minority Interest hit $830000.0 in Q1 2018 for Traws Pharma, roughly flat from $830000.0 in the prior quarter.
  • Across five years, Minority Interest topped out at $874000.0 in Q4 2014 and bottomed at $394000.0 in Q3 2014.
  • Average Minority Interest over 5 years is $761823.5, with a median of $830000.0 recorded in 2015.
  • On a YoY basis, Minority Interest climbed as much as 110.66% in 2015 and fell as far as 5.03% in 2015.
  • Traws Pharma's Minority Interest stood at $874000.0 in 2014, then decreased by 5.03% to $830000.0 in 2015, then changed by 0.0% to $830000.0 in 2016, then changed by 0.0% to $830000.0 in 2017, then changed by 0.0% to $830000.0 in 2018.
  • According to Business Quant data, Minority Interest over the past three periods came in at $830000.0, $830000.0, and $830000.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.